home / stock / abvc / abvc news

ABVC News and Press, ABVC BioPharma Inc. From 10/26/23

Stock Information
Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: NASDAQ
Website: abvcpharma.com
Menu
ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...
ABVC - ABVC shares jump after signing licensing deal for CNS drugs

2023-10-26 13:36:09 ET More on ABVC BioPharma ABVC looks to establish a healthcare center, buys 20% stake in real estate property ABVC stock rallies on Chinese licensing deal for psych drugs Financial information for ABVC BioPharma For further details see: ...
ABVC - 24/7 Market News Snapshot 26 Oct 2023

2023-10-26 09:56:15 ET DENVER, Colo., Oct. 26, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ABVC BioPharma Inc (NASDAQ: ABVC), PaxMedica Inc (NASDAQ: PXMD), TransCode Therapeutics Inc (NASDAQ: RNAZ), M...

ABVC - ABVC BioPharma to License Global Rights of CNS Drugs with the Indications of MDD and ADHD to AiBtl BioPharma for $667M

2023-10-26 09:02:11 ET DENVER, Colo., Oct 26, 2023 ( www.247marketnews.com )- ABVC BioPharma, Inc. (NASDAQ: ABVC) stated this morning, that it entered into a binding term sheet regarding a multi-year, global licensing agreement with AiBtl BioPharma for the Company’s CNS drugs wit...

ABVC - ABVC BioPharma Entered Into a Term Sheet to License Global Rights of CNS Drugs with the Indications of MDD and ADHD to AiBtl BioPharma at the Valuation of $667 Million

FREMONT, CA - ( NewMediaWire ) - October 26, 2023 -   ABVC BioPharma, Inc.  (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that it...
ABVC - ABVC BioPharma Announces Completion of Subject Recruitment for Interim Analysis on ADHD Phase IIb Clinical Study

FREMONT, CA - ( NewMediaWire ) - October 17, 2023 -   ABVC BioPharma, Inc . (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced an update on the Company's eight-week ...

ABVC - ABVC BioPharma Receives Taiwanese Patent for Its Treatment of Major Depressive Disorder (MDD)

The Company Holds a US Patent for the Same Treatment FREMONT, CA - ( NewMediaWire ) - October 09, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hemato...

ABVC - ABVC BioPharma Provides Updates on ADHD Phase IIb Clinical Study

FREMONT, CA - ( NewMediaWire ) - August 23, 2023 -   ABVC BioPharma, Inc . (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that 60 subjects had been enrolled and 53 had co...
ABVC - Fulcrum, Renovaro top healthcare gainers; Emergent, Geron among losers

2023-08-22 10:00:48 ET Gainers: Fulcrum Therapeutics ( FULC ) +55% . Renovaro Biosciences ( RENB ) +18% . ProMIS Neurosciences ( PMN ) +17% . cbdMD ( YCBD ) +9% . 60 Degrees Pharmaceuticals ( SXTP ) +7% . Losers: Emergent BioSo...

ABVC - ABVC looks to establish a healthcare center, buys 20% stake in real estate property

2023-08-17 13:26:45 ET More on ABVC BioPharma ABVC stock rallies on Chinese licensing deal for psych drugs Thailand FDA approves ABVC BioPharma's phase 2 study plan for its eye-gel substitute ABVC Biopharma stock rises on upcoming US patent for ABV-1504 to treat depres...

ABVC - ABVC Executes Cooperation Agreement for Strategic Investments

FREMONT, CA - ( NewMediaWire ) - August 17, 2023 -   ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it had entered into a Cooperation Agr...
Previous 10 Next 10